Usefulness of coadministration of bucolome in warfarin therapy: Pharmacokinetic and pharmacodynamic analysis using outpatient prescriptions

International Journal of Pharmaceutics

Volumn 293, Issue 1-2, 2005, Pages 43-49

  Osawa, Makiko ^a   Hada, Nobuko ^b   Matsumoto, Kaori ^b   Hasegawa, Tetsuya ^b   Kobayashi, Daisuke ^b   Morimoto, Yasunori ^b   Yamaguchi, Masatoshi ^c   Kanamoto, Ikuo ^d   Nakagawa, Teruaki ^e   Sugibayashi, Kenji ^b  

^a Sekishinkai Sayama Hospital   (Japan)

^b JOSAI UNIVERSITY   (Japan)

^c Niigata Prefectural Muikamachi Hospital   (Japan)

^d Hokuriku Central Hospital   (Japan)

^e Himi Municipal Hospital   (Japan)

Author keywords

Bucolome; Drug interaction; Enzyme inhibition; Pharmacodynamics; Pharmacokinetics; Warfarin

Indexed keywords

BUCOLOME; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG HALF LIFE; ENZYME INHIBITION; FEMALE; HEART INFARCTION; HUMAN; LIVER CLEARANCE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PHARMACODYNAMICS; PRESCRIPTION; PRIORITY JOURNAL; THROMBOTEST; VASCULAR DISEASE;

EID: 20144374559     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.12.009     Document Type: Article

References (15)

1. C. Banfield, R. O'Reilly, E. Chan, and M. Rowland Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations Br. J. Clin. Pharmacol. 16 1983 669 675
2. D. Deykin Warfarin therapy N. Engl. J. Med. 283 1970 691 694 801-803
3. N.H.G. Holford Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship Clin. Pharmacokinet. 11 1986 483 504
4. H. Ikuma, H. Wada, Y. Mori, M. Shimura, K. Hiyoyama, T. Nakasaki, M. Nishikawa, K. Onoda, N. Yamada, T. Ohta, J. Nishioka, T. Nobori, E.C. Gabazza, N. Sakuragawa, and H. Shiku Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombo-test monitoring Blood Coagul. Fibrinolysis 10 1999 429 434
5. W.J. Jusko, and H.C. Ko Pharmacodynamics and drug action. Physiologic indirect response models characterize diverse types of pharmacodynamic effects Clin. Pharmacol. Ther. 56 1984 406 419
6. J. Koch-Weser, and E.M. Sellers Drug interactions with coumarin anticoagulants N. Engl. J. Med. 285 1971 487 498 547-558
7. S.M. MacLeod, and E.M. Sellers Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants Drugs 11 1976 461 470
8. T. Majima, K. Hosono, and A. Kawabe A new method of anticoagulant therapy used by combination warfarin and bucolome Niigata Igaku Kai Zasshi 88 1982 95 119 (in Japanese)
9. M. Matsuoka Thrombosis therapy Geriatr. Med. 15 1977 505 512 (in Japanese)
10. Y. Numata, Y. Ogata, K. Arao, Y. Mizumasa, T. Wakita, H. Haruguchi, H. Araki, T. Tsuji, K. Mawatari, and K. Shimada Relationship between prothrombin time international normalized ratio and thrombo test (%) J. Cardiol. 38 2001 327 335 (in Japanese)
11. I. Sakashita, C. Nakamura, S. Ohtani, R. Hashimoto, M. Washio, and K. Asano Clinical significance of combination therapy of anticoagulations. Warfarin and bucolome in patients with artificial heart valve-particularly in those with Starr-Edward ball valve Shinzo 10 1978 400 406 (in Japanese)
12. N. Sakuragawa, K. Takahashi, J. Nomura, and I. Sakashita Anticoagulant therapy Acta Haematol. Jpn. 45 1982 830 833
13. H.G.M. Shetty, A.G. Fennerty, and P.A. Routledge Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy Clin. Pharmacokinet. 16 1989 238 253
14. H. Takahashi, T. Kashima, S. Kimura, N. Murata, T. Takaba, K. Iwade, T. Abe, H. Yasumori, and H. Echizen Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome. Application of in vitro approaches to predicting in vivo reduction of (S)-warfarin clearance Drug Metab. Disp. 27 1999 1179 1186
15. E.S. Vesell, and C.A. Shively Liquid chromatographic assay of warfarin: similarity of warfarin half-lives in human subjects Science 184 1974 466 468